BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 26754670)

  • 21. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
    PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.
    Dinh TK; Fendler W; Chałubińska-Fendler J; Acharya SS; O'Leary C; Deraska PV; D'Andrea AD; Chowdhury D; Kozono D
    Radiat Oncol; 2016 Apr; 11():61. PubMed ID: 27117590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer.
    Yin K; Liu M; Zhang M; Wang F; Fen M; Liu Z; Yuan Y; Gao S; Yang L; Zhang W; Zhang J; Guo B; Xu J; Liang H; Chen X; Guan W
    Oncotarget; 2016 Oct; 7(41):67321-67332. PubMed ID: 27634902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway.
    Lan F; Yue X; Ren G; Li H; Ping L; Wang Y; Xia T
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):73-81. PubMed ID: 25442346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.
    Wang Y; Chen T; Huang H; Jiang Y; Yang L; Lin Z; He H; Liu T; Wu B; Chen J; Kamp DW; Liu G
    Oncotarget; 2017 Mar; 8(12):20133-20144. PubMed ID: 28423618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
    Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
    FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
    Grosso S; Doyen J; Parks SK; Bertero T; Paye A; Cardinaud B; Gounon P; Lacas-Gervais S; Noël A; Pouysségur J; Barbry P; Mazure NM; Mari B
    Cell Death Dis; 2013 Mar; 4(3):e544. PubMed ID: 23492775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer.
    Liu X; Shi H; Liu B; Li J; Liu Y; Yu B
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):431-40. PubMed ID: 25935837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
    Zhang ZY; Fu SL; Xu SQ; Zhou X; Liu XS; Xu YJ; Zhao JP; Wei S
    Oncotarget; 2015 Jan; 6(3):1462-77. PubMed ID: 25596743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
    Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer.
    Zhao J; Fu W; Liao H; Dai L; Jiang Z; Pan Y; Huang H; Mo Y; Li S; Yang G; Yin J
    BMC Cancer; 2015 Oct; 15():731. PubMed ID: 26482648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
    Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
    Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression.
    Sun Y; Li L; Xing S; Pan Y; Shi Y; Zhang L; Shen Q
    Cancer Biomark; 2017 Dec; 20(4):597-608. PubMed ID: 28800319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.